drugset / Trial / NCT06207539

Induction of Abortion in the Second Trimester

NCT06207539

Phase 0 Completed 40 enrolled Ain Shams Maternity Hospital
RandomizedSequentialSingle-blindSupportive care

Summary

To compare between the effects of misoprostol with hyoscine N-butyl bromide and misoprostol alone on shortening the time of abortion induction in the second trimester.

Timeline

Start
2022-12-01
Primary completion
2023-03-30
Completion
2023-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Hyoscine butylbromide Unknown 20 mg Intramuscular
Background Misoprostol Other / unclassified 200 ug
Background Misoprostol Other / unclassified 400 ug

Indications

No indication recorded.